Literature DB >> 12793289

[Incidence of bacterial translocation in four different models of experimental short bowel syndrome].

A B Asensio1, N García-Urkia, P Aldazabal, P Bachiller, J M García-Arenzana, I Eizaguirre.   

Abstract

UNLABELLED: The outcome of patients with short bowel syndrome is influenced for factors such as the length of remnant intestine or the presence or absence of ileocecal valve (ICV). Gram-negative sepsis, the main cause of mortality in this group of children, is probably due to bacterial translocation (BT), because after gut resection there are a number of circumstances that favour its occurrence, being the most known intestinal dismotility, bacterial overgrowth, loss of gut-associated lymphoid tissue, total parenteral nutrition (TPN) and fasting related mucosal atrophy. The aim of this experimental controlled study was to test the incidence of BT after four different types of gut resection, in animals fed orally or receiving TPN. Hundred and three adult Wistar rats bred and raised in our facilities according to European Union Regulations were randomly divided in six groups:--Group 1 (n = 26): non-manipulated animals, served as a control.--Group 2 (n = 14): 80% non-lethal small bowel resection, fed orally.--Group 3 (n = 15): same resection as group 2 but including ICV. Rat chow ad libitum.--Group 4 (n = 27): non-resected fasting animals receiving all-in-one TPN solution.--Group 5 (n = 11): same resection as group 2, but fasting and receiving TPN--Group 6 (n = 10): 90% small bowel resection, including cecum and ICV, fasting and TPN. The animals were maintained for 10 days in individual metabolic cages, and, at the end of the experiment, were bled by portal and cardiac puncture. Mesenteric lymph nodes, peripheral and portal blood samples were cultured for BT. Non-manipulated rats (group 1) had lower BT incidence (8%) than resected ones (groups 2, 3, 5 and 6, 93%, 60%, 91%, 60%, p < 0.05) or animals non-resected, receiving TPN (group 4.51%, p < 0.05). When resection included ICV in orally fed rats BT index was also lower (group 3 vs group 2.60% vs 91%, p < 0.05). In TPN resected animals a drop was also found in BT when ICV and cecum were added to small bowel resection (group 6 vs group 5.60% vs 91%, p < 0.05). IN
CONCLUSION: 1. Gut resection is associated to a high degree of BT, even if the animals are fed orally. 2. Resection including ICV, produced less BT. 3. TPN-related BT was shown in half of the animals non resected. 4. TPN-resected rats had also less BT when ICV and cecum were removed.

Entities:  

Mesh:

Year:  2003        PMID: 12793289

Source DB:  PubMed          Journal:  Cir Pediatr        ISSN: 0214-1221


  5 in total

Review 1.  Advances in short bowel syndrome: an updated review.

Authors:  Igor Sukhotnik; Arnold G Coran; Alexander Kramer; Eitan Shiloni; Jorge G Mogilner
Journal:  Pediatr Surg Int       Date:  2005-11-03       Impact factor: 1.827

2.  Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome.

Authors:  Junqiang Tian; Li Hao; Prakash Chandra; Dean P Jones; Ifor R Willams; Andrew T Gewirtz; Thomas R Ziegler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-18       Impact factor: 4.052

3.  Critical assessment of the methods used for detection of bacterial translocation.

Authors:  F Hernandez Oliveros; Y Zou; G Lopez; M Romero; L Martínez; S González-Reyes; A García; P Peña; J A Tovar
Journal:  Pediatr Surg Int       Date:  2004-02-10       Impact factor: 1.827

4.  Presepsin Levels in Experimental Sepsis and Massive Bowel Resection Models in Rats.

Authors:  Ozlem Unay-Demirel; Seyda Ignak; Taner Orug; Meral Yuksel
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

5.  Small Bowel Resection Increases Paracellular Gut Barrier Permeability via Alterations of Tight Junction Complexes Mediated by Intestinal TLR4.

Authors:  Cathleen M Courtney; Emily J Onufer; Keely G McDonald; Allie E Steinberger; Anne M Sescleifer; Kristen M Seiler; Maria E Tecos; Rodney D Newberry; Brad W Warner
Journal:  J Surg Res       Date:  2020-09-28       Impact factor: 2.192

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.